DART eliminates the need for animal testing by using AI-driven simulations and in vitro platforms to predict safety concerns during R&D, clinical trials, and production phases.
DART supports a gradual reduction in animal testing by providing reliable predictions that decrease the number of animals needed, facilitating a transition to fully animal-free testing methods.
DART enhances testing precision and relevance to human physiology, integrating seamlessly into existing workflows and significantly reducing testing time.
Higher relevance to human physiology
No animal experimentation or biopsies
Cost effective modern approach
Enhanced prediction accuracy with ML models
Seamless integration into the company’s existing quality check workflow
Reduction in testing time drastically
An in-vitro platform that uses a human micro physiological system created from an ethically sourced biobank.
A digital workstation solution to predict safety concerns by comparing with benchmark patterns derived through segmentation model training to provide accurate predictions.
Batch TestingPrediction of neurovirulence and sterility in the vaccine production workflow
Prediction of neurovirulence in viral vaccine development process
Antivenom EfficacyPrediction of antivenom potency and effectiveness
Prediction of CAR-T cell therapy-induced neurotoxicity
Quantiphi is an award-winning AI-first digital engineering company driven by the desire to reimagine and realize transformational opportunities at the heart of business. We are passionate about our customers and obsessed with problem-solving to make products smarter, customer experiences frictionless, processes autonomous and businesses safer.
